Hendrikse NH - Search Results

1

Dynamics of multidrug resistance: P-glycoprotein analyses with positron emission tomography.

Hendrikse NH, Vaalburg W. Hendrikse NH, et al. Methods. 2002 Jul;27(3):228-33. doi: 10.1016/s1046-2023(02)00079-8. Methods. 2002. PMID: 12183111

2

An oncological view on the blood-testis barrier.

Bart J, Groen HJ, van der Graaf WT, Hollema H, Hendrikse NH, Vaalburg W, Sleijfer DT, de Vries EG. Bart J, et al. Among authors: hendrikse nh. Lancet Oncol. 2002 Jun;3(6):357-63. doi: 10.1016/s1470-2045(02)00776-3. Lancet Oncol. 2002. PMID: 12107023 Review.

3

Quantitative assessment of P-glycoprotein function in the rat blood-brain barrier by distribution volume of [11C]verapamil measured with PET.

Bart J, Willemsen AT, Groen HJ, van der Graaf WT, Wegman TD, Vaalburg W, de Vries EG, Hendrikse NH. Bart J, et al. Among authors: hendrikse nh. Neuroimage. 2003 Nov;20(3):1775-82. doi: 10.1016/s1053-8119(03)00405-1. Neuroimage. 2003. PMID: 14642487

4

In vivo imaging of hepatobiliary transport function mediated by multidrug resistance associated protein and P-glycoprotein.

Hendrikse NH, Kuipers F, Meijer C, Havinga R, Bijleveld CM, van der Graaf WT, Vaalburg W, de Vries EG. Hendrikse NH, et al. Cancer Chemother Pharmacol. 2004 Aug;54(2):131-8. doi: 10.1007/s00280-004-0793-2. Epub 2004 Apr 30. Cancer Chemother Pharmacol. 2004. PMID: 15118837

5

PET Studies on P-glycoprotein function in the blood-brain barrier: how it affects uptake and binding of drugs within the CNS.

Elsinga PH, Hendrikse NH, Bart J, Vaalburg W, van Waarde A. Elsinga PH, et al. Among authors: hendrikse nh. Curr Pharm Des. 2004;10(13):1493-503. doi: 10.2174/1381612043384736. Curr Pharm Des. 2004. PMID: 15134571 Review.

6

Blood-brain barrier dysfunction in parkinsonian midbrain in vivo.

Kortekaas R, Leenders KL, van Oostrom JC, Vaalburg W, Bart J, Willemsen AT, Hendrikse NH. Kortekaas R, et al. Among authors: hendrikse nh. Ann Neurol. 2005 Feb;57(2):176-9. doi: 10.1002/ana.20369. Ann Neurol. 2005. PMID: 15668963

7

Positron emission tomography studies on binding of central nervous system drugs and P-glycoprotein function in the rodent brain.

Elsinga PH, Hendrikse NH, Bart J, van Waarde A, Vaalburg W. Elsinga PH, et al. Among authors: hendrikse nh. Mol Imaging Biol. 2005 Jan-Feb;7(1):37-44. doi: 10.1007/s11307-005-0951-x. Mol Imaging Biol. 2005. PMID: 15912274 Review.

8

New positron emission tomography tracer [(11)C]carvedilol reveals P-glycoprotein modulation kinetics.

Bart J, Dijkers EC, Wegman TD, de Vries EG, van der Graaf WT, Groen HJ, Vaalburg W, Willemsen AT, Hendrikse NH. Bart J, et al. Among authors: hendrikse nh. Br J Pharmacol. 2005 Aug;145(8):1045-51. doi: 10.1038/sj.bjp.0706283. Br J Pharmacol. 2005. PMID: 15951832 Free PMC article.

9

Carbon-11-labeled daunorubicin and verapamil for probing P-glycoprotein in tumors with PET.

Elsinga PH, Franssen EJ, Hendrikse NH, Fluks L, Weemaes AM, van der Graaf WT, de Vries EG, Visser GM, Vaalburg W. Elsinga PH, et al. Among authors: hendrikse nh. J Nucl Med. 1996 Sep;37(9):1571-5. J Nucl Med. 1996. PMID: 8790221 Free article.

10

99mTc-sestamibi is a substrate for P-glycoprotein and the multidrug resistance-associated protein.

Hendrikse NH, Franssen EJ, van der Graaf WT, Meijer C, Piers DA, Vaalburg W, de Vries EG. Hendrikse NH, et al. Br J Cancer. 1998;77(3):353-8. doi: 10.1038/bjc.1998.57. Br J Cancer. 1998. PMID: 9472628 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

103 results

Search Page